Establishment of Acenocoumarol Pharmacogenetic Algorithm Including CYP2C9 and VKORC1 Genotypes in Bulgarian Patients Treated with Coumarin Anticoagulants
19 giu 2025
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 19 giu 2025
Pagine: 12 - 23
Ricevuto: 22 ago 2024
Accettato: 03 feb 2025
DOI: https://doi.org/10.2478/amb-2025-0039
Parole chiave
© 2025 R. Tzveova et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Saraeva, R.
Eurofins Biomnis – LyonFrance
Dimitrova-Karamfilova, A.
Department of Clinical Laboratory, XXV Diagnostic Consultative Center – SofiaBulgaria
Nachev, G.
Department of Cardiovascular Surgery, University Multiprofile Hospital for Active Treatment “Sv. Ekaterina” – SofiaBulgaria
Mitev, V.
Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University – SofiaBulgaria
Kaneva, R.
Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University – SofiaBulgaria
Pendicheva-Duhlenska, D.
Department of Pharmacology, Faculty of Pharmacy, Medical University – PlevenBulgaria